Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, 5138663134, Iran.
Department of Biology, Faculty of Basic Sciences, Azarbaijan Shahid Madani University, Tabriz, 537517169, Iran.
Reprod Biol Endocrinol. 2020 Aug 5;18(1):78. doi: 10.1186/s12958-020-00638-4.
Premature Ovarian Insufficiency (POI) is viewed as a type of infertility in which the menopausal status occurs before the physiological age. Several therapeutic strategies have been introduced in clinic for POI treatment, although the outputs are not fully convincing. Platelet-rich plasma (PRP) is a unique blood product widely applied in regenerative medicine, which is based on the releasing of the growth factors present in platelets α-granules. In the current investigation, we examined the effectiveness of PRP as a therapeutic alternative for POI animals. POI in Wistar albino rats was induced by daily intraperitoneal (IP) administration of gonadotoxic chemical agent, 4-vinylcyclohexene dioxide (VCD) (160 mg/ kg) for 15 consecutive days. After POI induction, the PRP solution was directly injected intra-ovarian in two concentrations via a surgical intervention. Every two weeks post-injection, pathological changes were monitored in the ovaries using Hematoxylin-Eosin staining method, until eight weeks. Follicle Stimulating Hormone (FSH) content in serum was measured, together with the expression of the angiogenic-related transcripts ANGPT2 and KDR by real-time qPCR. Furthermore the fertility status of the treated rats was evaluated by mating trials. Histopathological examination revealed successful POI induction via the depletion of morphologically normal follicles in rats following VCD treatment compared to the control rats. The injection of PRP at two concentrations reduced the number and extent of the follicular atresia and inflammatory responses (p < 0.05). The expression of both ANGPT2 and KDR transcripts were significantly increased in POI rats due to enhanced inflammation, while these values were modulated after PRP administration (p < 0.05) compared to POI rats. FSH showed a decreased trend in concentration eight weeks after PRP treatment, but not statistically significant (p > 0.05). Nevertheless, a clear improvement in litter counts was found in POI rats receiving PRP compared to the non-treated POI group, being able to consider PRP as a facile, quick, accessible, safe and relatively cheap alternative therapeutic strategy to revert POI-related pathologies.
卵巢早衰(POI)被视为一种在生理年龄之前发生绝经状态的不孕症。临床上已经引入了几种治疗 POI 的策略,尽管结果并不完全令人信服。富含血小板的血浆(PRP)是一种广泛应用于再生医学的独特血液产品,它基于释放血小板α颗粒中存在的生长因子。在当前的研究中,我们研究了 PRP 作为 POI 动物治疗替代物的有效性。通过连续 15 天每天腹膜内(IP)给予性腺毒性化学剂 4-乙烯环己烯二氧化物(VCD)(160mg/kg)诱导 Wistar 白化大鼠的 POI。POI 诱导后,通过手术干预将 PRP 溶液直接注入卵巢内两种浓度。注射后每两周,通过苏木精-伊红染色法监测卵巢的病理变化,直到 8 周。通过实时 qPCR 测量血清中卵泡刺激素(FSH)的含量以及血管生成相关转录物 ANGPT2 和 KDR 的表达。此外,通过交配试验评估治疗大鼠的生育状况。组织病理学检查显示,与对照组大鼠相比,VCD 处理后大鼠形态正常的卵泡耗竭成功诱导 POI。两种浓度的 PRP 注射减少了卵泡闭锁和炎症反应的数量和程度(p<0.05)。由于炎症增强,POI 大鼠中 ANGPT2 和 KDR 转录物的表达显着增加,而 PRP 给药后这些值得到调节(p<0.05)与 POI 大鼠相比。PRP 治疗 8 周后,FSH 的浓度呈下降趋势,但无统计学意义(p>0.05)。尽管如此,与未治疗的 POI 组相比,接受 PRP 的 POI 大鼠的产仔数明显增加,可将 PRP 视为一种简便、快速、易于获得、安全且相对便宜的替代治疗策略,可逆转与 POI 相关的病理。